Pieris Pharmaceuticals
PIRS
#9791
Rank
NZ$31.78 M
Marketcap
$24.07
Share price
-15.58%
Change (1 day)
19.90%
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -NZ$36.58 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are NZ$19.57 Million. In 2022 the company made an earning of -NZ$58.91 Million, an increase over its 2021 earnings that were of -NZ$80.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$36.58 Million
2022 -NZ$58.91 Million-27.24%
2021 -NZ$80.97 Million23.4%
2020 -NZ$65.62 Million45.53%
2019 -NZ$45.09 Million-5.89%
2018 -NZ$47.91 Million63.59%
2017 -NZ$29.29 Million-26.92%
2016 -NZ$40.08 Million63.39%
2015 -NZ$24.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.15 Billion 258.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$9.71 Million-75.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.31 B-895.62%๐Ÿ‡บ๐Ÿ‡ธ USA